Hypertension in the elderly

Current Hypertension Reports

Volumn 6, Issue 6, 2004, Pages 469-476

  Sander, Gary E ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; ALPHA ADRENERGIC RECEPTOR; AMILORIDE; ANGIOTENSIN; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CATECHOLAMINE; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ELECTROLYTE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HYDROCHLOROTHIAZIDE; NITRENDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN; PLACEBO; POTASSIUM; RENIN; THIAZIDE DIURETIC AGENT; TRANDOLAPRIL; TRIACYLGLYCEROL; UNINDEXED DRUG; URIC ACID; VERAPAMIL;

ADRENERGIC SYSTEM; AGED; AGING; AORTA DISEASE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG SAFETY; EDEMA; ELECTROLYTE DISTURBANCE; FATALITY; GERIATRIC DISORDER; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPERURICOSURIA; HYPOKALEMIA; KIDNEY DYSFUNCTION; LOW DRUG DOSE; MEDICAL DECISION MAKING; METABOLIC DISORDER; NEUROENDOCRINE SYSTEM; ORTHOSTATIC HYPOTENSION; PATHOLOGY; PULSE PRESSURE; REVIEW; RISK ASSESSMENT; SODIUM RESTRICTION; STROKE; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; TREATMENT PLANNING; VASCULAR DISEASE;

EID: 10044254245     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-004-0043-3     Document Type: Review

References (50)

1. Moser M, Cushman W, Oparil S, Glasser S: Treating hypertension in the elderly: whom to treat, when, and with what? J Clin Hypertens 2001, 3:103-109.
2. Basile JN: Treatment of the elderly hypertensive: systolic hypertension. In Hypertension Primer, edn 3. Edited by Izzo JL Jr, Black HR. Dallas: American Heart Association; 2003:446-449.
3. Rajala S, Haavisto M, Heikinheimo R, Mattila K: Blood pressure and mortality in the very old. Lancet 1983, 2: 20-521.
4. Paran E, Anson O, Reuveni H: Blood pressure and cognitive functioning among independent elderly. J Hypertens 2003, 16: 18-826.
5. Burt VL, Whelton P, Roccella EJ, et al.: Prevalence of hypertension in the US adult population: results from the third National Health and Nutrition Examination Survery, 1988-1991. Hypertension 1995, 25:305-313.
6. Lloyd-Jones DM, Evans JC, Levy D: Epidemiology of hypertension in the old-old: data from the community in the 1990s. Am J Hypertens 2004, 17:200A.
7. Chobanian AV, Bakris GL, Black HR, et al.: National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289:2560-2572.
8. Williams B, Poulter NR, Brown MJ, et al.: BHS guidelines working party, for the British Hypertension Society. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004, 328:634-640.
9. Cushman WC: The clinical significance of systolic hypertension. Am J Hypertens 1998, 11(Pt 2):182S-185S.
10. National High Blood Pressure Education Program Working Group: National High Blood Pressure Education Program Working Group report on hypertension in the elderly. Hypertension 1994, 23: 75-285.
11. Benetos A, Thomas F, Bean K, et al.: Prognostic value of systolic and diastolic blood pressure in treated hypertensive men. Arch Intern Med 2002, 162:577-581.
12. Nichols WW, Nicolini FA, Pepine CJ: Determinants of isolated systolic hypertension in the elderly. J Hypertens 1992, 10(Suppl 6):S73-S77.
13. Stokes GS: Systolic hypertension in the elderly: pushing the frontiers of therapy - a suggested new approach. J Clin Hypertens 2004, 6:192-197.
14. Mitchell GF, Lacourciere Y, Ouellet JF, et al.: Determinants of elevated pulse pressure in middle-aged and older subjects with uncomplicated systolic hypertension: the role of proximal aortic diameter and the aortic pressure-flow relationship. Circulation 2003, 108:1592-1598,
15. Franklin SS, Gustin WG, Wong ND, et al.: Hemodynamic patterns of age-related changes in blood pressure: the Framingham Heart Study. Circulation 1997, 96:308-315.
16. Wiinberg N, Hoegholm A, Christensen HR, et al.: 24-H ambulatory blood pressure in 352 normal Danish subjects, related to age and gender. Am J Hypertens 1995, 8:978-986.
17. Fotherby MD, Potter JF: Twenty-four-hour ambulatory blood pressure in old and very old subjects. J Hypertens 1995, 13(12 Pt 2):1742-1746.
18. Bobrie G, Chatellier G, Genes N, et al.: Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004, 291:1342-1349.
19. Crane MG, Harris JJ: Effect of aging on renin activity and aldosterone secretion. J Lab Clin Med 1976, 87:947-959.
20. Abraham K, Lowenthal DT: Hypertension in the elderly. In Hypertension: A Companion to Brenner and Rector's The Kidney. Edited by Oparil S, Weber MA. Philadelphia: WB Saunders; 2000:551-558.
21. Zemel MB, Sowers J: Salt sensitivity and systemic hypertension in the elderly. Am J Cardiol 1988, 61:7H-12H.
22. Oui WL, Barrett S, Houssain M, et al.: Patterns of orthostatic blood pressure change and their clinical correlates in a frail, elderly population. JAMA 1997, 277:1299-1304.
23. Applegate WB, Davis BR, Black HR, et al.: Prevalence of postural hypotension at baseline in the Systolic Hypertension in the Elderly Program (SHEP) cohort. J Amer Geriatr Soc 1991, 39: 057-1064.
24. Spence JD, Sibbald WJ, Cape RD: Direct, indirect and mean blood pressures in hypertensive patients: the problem of cuff artifact due to arterial wall stiffness, and a partial solution. Clin Invest Med 1980, 2:165-173.
25. Moser M: Results of therapy. In Clinical Management of Hypertension, edn 2. Edited by Moser M. Caddo, OK: Professional Communications; 2004:247-268.
26. Sander GE: High blood pressure in the geriatric population: treatment considerations. Am J Geriatr Cardiol 2002, 11:223-232.
27. MacMahon S, Rodgers A: The effects of blood pressure reduction in older patients: an overview of five randomized controlled trials in elderly hypertensives. Clin Exp Hyperten 1993, 15: 67-978.
28. Staessen JA, Gasowski J, Wang JG, et al.: Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000, 355:865-872.
29. Staessen JA, Fagard R, Thijs L, et al.: Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial. Lancet 1997, 350:757-764.
30. Forette F, Seux ML, Staessen JA, et al.: Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998, 352: 347-1351.
31. Hansson L, Lindholm LH, Ekbom T, et al.: Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 1999, 354:1751-1756.
32. Ekbom T, Linjer E, Hedner T, et al.: Cardiovascular events in elderly patients with isolated systolic hypertension: a subgroup analysis of treatment strategies in STOP-Hypertension-2. Blood Press 2004, 13:137-141.
33. Pepine CJ, Handberg EM, Cooper-DeHoff RM, et al.: A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA 2003, 290:2805-2816.
34. Kostis JB, Espeland MA, Appel L, et al.: Does withdrawal of antihypertensive medication increase the risk of cardiovascular events? Trial of Nonpharmacologic Interventions in the Elderly (TONE) Cooperative Research Group. Amer J Cardiol 1998, 82:1501-1508.
35. Savage PJ, Pressel SL, Curb JD, et al.: Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group. Arch Intern Med 1998, 158:741-751.
36. Pahor M, Shorr RI, Somes GW, et al.: Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the systolic hypertension in the elderly program Arch Intern Med 1998, 158:1340-1345.
37. Franse LV, Pahor M, DiBari M, et al.: Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program. Hypertension 2000, 35: 025-1030.
38. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002, 28: 981-2997.
39. Verdecchia P, Reboldi G, Angeli F, et al.: Adverse prognostic significance of new diabetes in treated hypertensive subjects Hypertension 2004, 43:963-969.
40. Laragh J: Laragh's lessons in pathophysiology and clinical pearls for treating hypertension. Am J Hypertens 2001, 14: 4-89.
41. Bakris GL, Williams M, Dworkin L, et al.: Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kid Dis 2000, 36:646-661.
42. de Leeuw PW: Nonsteroidal anti-inflammatory drugs and hypertension: the risks in perspective. Drugs 1996, 51: 79-187.
43. Johnson AG: NSAIDs and increased blood pressure. What is the clinical significance? Drug Safety 1997, 17:277-289.
44. Whelton A, Schulman G, Wallemark C, et al.: Effects of celecoxib and naproxen on renal function in the elderly. Arch Intern Med 2000, 160:1465-1470.
45. Silverstein FE, Faich G, Goldstein JL, et al.: Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. The CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 2000, 284:1247-1255.
46. Staessen JA: Potential adverse effects of blood pressure lowering: J-curve revisited. Lancet 1996, 348:696-697.
47. Somes GW, Pahor M, Short RI, et al.: The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med 1999, 159:2004-2009.
48. Messerli FH, Grossman E, Goldbourt U: Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. JAMA 1998, 279:1903-1907.
49. Collins R, Peto R, MacMahon S, et al.: Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions ingblood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990, 335:827-838.
50. Forette F, Seux ML, Staessen JA et al.: Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998, 352: 347-1351.